February Newsletter/Institute for Commercialization of Florida Technology 3.1.19
Issue 75 – February 2019
Merck Animal Health and Rapid Genomics Sign Exclusive Agreement on Vaccine Verification
Merck Animal Health, a division of Merck & Co., Inc., announced a collaboration agreement with Rapid Genomics, a company funded by the Institute in 2015....
January Newsletter/Institute for Commercialization of Florida Technology 2.1.19
Issue 74 – January 2019
Institute for Commercialization of Florida Technology and Florida Funders Partner to Drive New Innovation Investment Statewide
The Board of Directors of the Institute has selected Florida Funders to manage the investment-related affairs of the...
Institute for Commercialization of Florida Technology and Florida Funders Partner to Drive New Innovation Investment Statewide 1.29.19
Boca Raton and Tampa, FL – January 29, 2019 -- The Institute for Commercialization of Florida Technology (the Institute), a not-for-profit organization focused on innovation and entrepreneurship across the state, is pleased to announce that its Board of Directors has selected Florida Funders to...
December Newsletter/Institute for Commercialization of Florida Technology 1.7.19
Issue 73 – December 2018
Holiday Greetings from the Florida Institute
January 23 - 24, 2019 Amalie Arena, Tampa, FL
Register today for the Synapse Summit and be part of a new environment that is fueling innovation in Tampa Bay. The Synapse Summit brings together the...
November Newsletter/ Institute for Commercialization of Florida Technology 11.30.18
Issue 72 - November 2018
Entrinsic Health Solutions and Nestlé Health Science Enter Global Partnership for Novel Amino Acid Product enterade®
Entrinsic Health Solutions (EHS), an innovative health sciences company, announced that they have entered into a partnership with Nestlé Health...
Share
